Join us for this exclusive invitational forum that provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem. Nearly 100% of attendees agreed the content, topics, sessions, and information were relevant and up-to-date.
Attend our presentation
Near-Term Oncology Drug Trend and Pipeline Review
Time: 7:15AM EST
Day: October 20, 2022
Moderator: Cheryl Allen, RPh, BSPharm
- Jeffrey Bockman, PhD, EVP, BioConsulting, Head of Oncology, Lumanity
- Dipti Shah, PharmD, Senior Clinical Program Manager, CVS Specialty
- Doug Long, VP, Industry Relations, IQVIA
With 75% of the pharmaceutical research and development focused on cancer drug development, this panel will explore and summarize the near-term innovative drugs and gene therapies coming to market in the next year. Additionally, the panel will provide an assessment on the impact and trends on the new cancer drug technologies and label expansions will have on the cancer care ecosystem.
Click here to register!